Published in Am J Hypertens on December 01, 2000
Racial Variation in ACE--Genetic and Physiologic Bases | NCT00005757
The role of the kallikrein-kinin system genes in the salt sensitivity of blood pressure: the GenSalt Study. Am J Epidemiol (2012) 0.82
High salt-induced hypertension in B2 knockout mice is corrected by the ETA antagonist, A127722. Br J Pharmacol (2013) 0.78
Bradykinin β2 receptor -58T/C gene polymorphism and essential hypertension: a meta-analysis. PLoS One (2012) 0.78
The risk of bradykinin B2 receptor-58T/C gene polymorphism on hypertension: a meta-analysis. Int J Clin Exp Med (2015) 0.75
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept. Pharmaceuticals (Basel) (2010) 0.75
Bradykinin type-2 receptor expression correlates with age and is subjected to transcriptional regulation. Int J Vasc Med (2011) 0.75
Association between the CYP4A11 T8590C variant and essential hypertension: new data from Han Chinese and a meta-analysis. PLoS One (2013) 0.75
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol (2002) 8.27
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med (1998) 3.18
A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature (1991) 2.80
The B1 receptors for kinins. Pharmacol Rev (1998) 2.32
Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res (1997) 2.27
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol (2001) 2.26
Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis (2001) 2.14
Measurement of gastric emptying time with a gamma camera. Lancet (1970) 2.08
Energy and environment. Methane leaks from North American natural gas systems. Science (2014) 2.05
Neuropilins in physiological and pathological angiogenesis. J Pathol (2007) 2.03
Primary sequence of the glucanase gene from Oerskovia xanthineolytica. Expression and purification of the enzyme from Escherichia coli. J Biol Chem (1991) 1.75
Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo. Br J Pharmacol (1987) 1.56
Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin. Br J Pharmacol (1988) 1.53
Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol (1983) 1.47
De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol (1978) 1.45
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation (2001) 1.44
The Bristol Bladder Tumour Registry. Br J Urol (1969) 1.42
Muscle blood-flow studies by the technetium (99mTc) clearance technique in normal subjects and in patients with intermittent claudication. Br J Surg (1971) 1.40
Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol (1981) 1.29
Possible medication errors in home healthcare patients. J Am Geriatr Soc (2001) 1.27
Proteolysis in human breast and colorectal cancer. Br J Cancer (1999) 1.27
Determination of plasmid copy number by the "boiling" method. Anal Biochem (1987) 1.25
Perinatal mortality and neonatal survival in Avon: 1976-9. Br Med J (Clin Res Ed) (1981) 1.25
Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer (2006) 1.24
Phasic abnormalities of left ventricular emptying in coronary artery disease. Br Heart J (1981) 1.21
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury. Kidney Int (2006) 1.19
C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes. Am J Pathol (1987) 1.18
Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer (2002) 1.18
The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation. Eur J Pharmacol (1987) 1.17
Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med (1999) 1.15
Emission computerised tomography. A new diagnostic imaging technique. Lancet (1978) 1.14
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens (2006) 1.12
Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy (2009) 1.11
p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol Heart Circ Physiol (2000) 1.10
Kinin receptors. Clin Rev Allergy Immunol (1998) 1.10
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut (2000) 1.10
Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer (2006) 1.09
Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl (1994) 1.09
Airway re-narrowing following deep inspiration in asthmatic and nonasthmatic subjects. Eur Respir J (2003) 1.08
Cardiovascular actions of kinins in the rabbit. Can J Physiol Pharmacol (1979) 1.08
Teratomas and yolk-sac tumours. J Clin Pathol (1976) 1.08
Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol Pathol (2002) 1.08
A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levels. Clin Genet (2002) 1.08
BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J Pathol (2008) 1.07
Pharmacological modulation of the up-regulated responses to des-Arg9-bradykinin in vivo and in vitro. Immunopharmacology (1989) 1.06
Computer-assisted blood background subtraction (CABBS) renography in obstructive nephropathy. Proc R Soc Med (1970) 1.06
Parametric imaging using digital subtraction angiography. Br J Radiol (1986) 1.05
Kinin receptors in experimental inflammation. Can J Physiol Pharmacol (1980) 1.05
Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J Immunol (1998) 1.05
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides (2000) 1.04
Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. Br J Surg (2009) 1.04
Proteolysis in human breast cancer. Mol Pathol (2000) 1.03
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int (1996) 1.02
Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of alpha-thrombin in rabbit aortic rings. Br J Pharmacol (1992) 1.02
The effects of body weight on airway calibre. Eur Respir J (2005) 1.02
Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. J Pharmacol Exp Ther (1991) 1.02
A new transverse-section brain imager for single-gamma emitters. J Nucl Med (1979) 1.02
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology (1999) 1.01
Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J Pharmacol Exp Ther (2001) 1.00
The use of the radioactive renogram in the reticuloses. Br J Radiol (1969) 1.00
Xenon washout. Lancet (1971) 1.00
Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels. J Pharmacol Exp Ther (1984) 1.00
Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor. Hypertension (2000) 0.99
Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol (1999) 0.99
Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer (1997) 0.98
Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther (2004) 0.98
Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation (2000) 0.98
Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther (2000) 0.98
Synthetic C5a receptor agonists. Pharmacology, metabolism and in vivo cardiovascular and hematologic effects. Biochem Pharmacol (1993) 0.98
Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br J Cancer (2009) 0.97
Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension (1998) 0.97
Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth (2010) 0.96
Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett (1994) 0.96
Separate origins of the left internal and external carotid arteries directly from the aortic arch: duplex sonographic findings. J Ultrasound Med (1995) 0.96
Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol (1996) 0.95
Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1. Br J Pharmacol (1991) 0.95
Altered frequency of a promoter polymorphic allele of the kinin B1 receptor gene in inflammatory bowel disease. Gastroenterology (1998) 0.95
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy (2010) 0.95
The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. Br J Cancer (1998) 0.94
The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clin Pharmacol Ther (2007) 0.94
The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. Br J Cancer (1995) 0.94
The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms. Clin Genet (2002) 0.94
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. Diabetologia (2011) 0.94
Angiopoietin-1, angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarring. Br J Dermatol (2010) 0.94
Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin. Can J Physiol Pharmacol (1981) 0.93
Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Br J Pharmacol (1993) 0.93
Selective induction of cardiovascular responses to des-Arg9-bradykinin by bacterial endotoxin. Pharmacology (1984) 0.92
Effects of intestinal ischemia-reperfusion injury on rat peripheral blood neutrophil activation. Dig Dis Sci (2003) 0.91
The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J Pathol (1996) 0.91
Cloning and pharmacological characterization of the rabbit bradykinin B2 receptor. J Pharmacol Exp Ther (1995) 0.90
Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics (1999) 0.90
The kinin B1 receptor: an inducible G protein coupled receptor. Can J Physiol Pharmacol (1997) 0.89
Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol (1996) 0.89
Proteolysis in colorectal cancer. Mol Pathol (1999) 0.89